{"id":"https://openalex.org/W4367304062","doi":"https://doi.org/10.1212/wnl.0000000000202504","title":"Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox\u2013Gastaut syndrome (LGS): The Caregiver Perspective (P14-1.002)","display_name":"Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox\u2013Gastaut syndrome (LGS): The Caregiver Perspective (P14-1.002)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304062","doi":"https://doi.org/10.1212/wnl.0000000000202504"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000202504","doi":"https://doi.org/10.1212/wnl.0000000000202504","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202504","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011081784","display_name":"Drishti Shah","orcid":"https://orcid.org/0000-0002-5866-7743","observed_orcids":["https://orcid.org/0000-0002-5866-7743"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Drishti Shah","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110751025","display_name":"Scott D. Andrews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Scott Andrews","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089880100","display_name":"Alise Nacson","orcid":"https://orcid.org/0009-0004-9532-4274","observed_orcids":["https://orcid.org/0009-0004-9532-4274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alise Nacson","raw_affiliation_strings":["Clinical Outcomes Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Solutions","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062219583","display_name":"Tara L. Symonds","orcid":"https://orcid.org/0000-0001-9145-5753","observed_orcids":["https://orcid.org/0000-0001-9145-5753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tara Symonds","raw_affiliation_strings":["Clinical Outcomes Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Solutions","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111108333","display_name":"Sophie L. Hughes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophie Hughes","raw_affiliation_strings":["Clinical Outcomes Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Solutions","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020934264","display_name":"Arturo Benitez","orcid":"https://orcid.org/0000-0001-6023-9871","observed_orcids":["https://orcid.org/0000-0001-6023-9871"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Arturo Benitez","raw_affiliation_strings":["Takeda Pharmaceutical Company Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Limited","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067044524","display_name":"Lara Sams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lara Sams","raw_affiliation_strings":["Clinical Outcomes Solutions"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Outcomes Solutions","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3298,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.53535703,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13117","display_name":"Health Education and Validation","score":0.03500000014901161,"subfield":{"id":"https://openalex.org/subfields/2922","display_name":"Research and Theory"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10467","display_name":"Psychometric Methodologies and Testing","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dravet-syndrome","display_name":"Dravet syndrome","score":0.9350000023841858},{"id":"https://openalex.org/keywords/lennox-gastaut-syndrome","display_name":"Lennox-Gastaut syndrome","score":0.9919999837875366},{"id":"https://openalex.org/keywords/clinician-reported-outcome-measures","display_name":"clinician-reported outcome measures","score":0.7799999713897705},{"id":"https://openalex.org/keywords/caregiver-perspectives","display_name":"caregiver perspectives","score":0.5789999961853027},{"id":"https://openalex.org/keywords/cognitive-debriefing","display_name":"cognitive debriefing","score":0.7799999713897705},{"id":"https://openalex.org/keywords/communication","display_name":"communication","score":0.6880000233650208},{"id":"https://openalex.org/keywords/alertness","display_name":"alertness","score":0.996999979019165},{"id":"https://openalex.org/keywords/disruptive-behavior","display_name":"disruptive behavior","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.5460000038146973},{"id":"https://openalex.org/keywords/item-relevance","display_name":"item relevance","score":0.4659999907016754},{"id":"https://openalex.org/keywords/concept-elicitation","display_name":"concept elicitation","score":0.49000000953674316},{"id":"https://openalex.org/keywords/parents-of-children-with-epilepsy","display_name":"parents of children with epilepsy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/intellectual-disability","display_name":"intellectual disability","score":0.5149999856948853},{"id":"https://openalex.org/keywords/developmental-delay","display_name":"developmental delay","score":0.9259999990463257}],"concepts":[{"id":"https://openalex.org/C202695956","wikidata":"https://www.wikidata.org/wiki/Q2669680","display_name":"Debriefing","level":2,"score":0.8940161466598511},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6600431203842163},{"id":"https://openalex.org/C75969862","wikidata":"https://www.wikidata.org/wiki/Q5141215","display_name":"Cognitive interview","level":3,"score":0.5677437782287598},{"id":"https://openalex.org/C551499885","wikidata":"https://www.wikidata.org/wiki/Q183560","display_name":"Intellectual disability","level":2,"score":0.5648072361946106},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4670635163784027},{"id":"https://openalex.org/C200678441","wikidata":"https://www.wikidata.org/wiki/Q1423044","display_name":"Alertness","level":2,"score":0.45148900151252747},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.44971877336502075},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.41645917296409607},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2565735876560211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19916817545890808},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.11422127485275269},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000202504","doi":"https://doi.org/10.1212/wnl.0000000000202504","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202504","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4407841277","https://openalex.org/W4414407015","https://openalex.org/W2766832340","https://openalex.org/W6939220757","https://openalex.org/W7171950947","https://openalex.org/W4389448814","https://openalex.org/W4392861579","https://openalex.org/W2736365965","https://openalex.org/W4405749936","https://openalex.org/W4294589519"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"report":[2],"the":[3,16,62,65,74,125,165,172,186,200,206,257],"results":[4],"of":[5,9,20,64,140,178,236,291,315,328,349,364,389],"interviews":[6],"with":[7,11,83],"caregivers":[8,80,100,123,184,223],"patients":[10,56,141],"DS":[12,41,147],"and":[13,37,42,49,67,78,106,169,190,198,211,238,265,270],"LGS":[14,43,151],"debriefing":[15,108],"Clinical":[17,350],"Global":[18],"Impression":[19],"Improvement":[21],"for":[22,34,180,249,310,323,344,359,384],"Nonseizure":[23],"Symptoms,":[24],"a":[25],"clinician-reported":[26],"outcome":[27],"(ClinRO)":[28],"measure":[29,75,85,126,258],"to":[30,71,116,158,170,175,268,370,376,396],"assess":[31],"within-patient":[32],"change":[33,179],"communication,":[35],"alertness":[36,201],"disruptive":[38,207],"behavior.":[39],"Background:":[40],"are":[44],"characterized":[45],"by":[46,93,298],"treatment-resistant":[47],"seizures":[48],"developmental":[50],"delay":[51],"and/or":[52],"intellectual":[53],"disability.":[54],"Because":[55],"cannot":[57],"self-report,":[58],"caregiver":[59,218],"feedback":[60,254],"on":[61,232],"relevance":[63],"concepts":[66],"methodology":[68],"is":[69,76,287],"critical":[70],"ensure":[72],"(a)":[73],"fit-for-purpose":[77],"(b)":[79],"can":[81],"assist":[82],"ClinRO":[84],"completion.":[86],"Design/Methods:":[87],"Caregivers":[88,155],"were":[89,138,156,225,266],"recruited":[90],"via":[91],"advertisement":[92],"advocacy":[94],"organizations":[95],"(January\u2013March":[96],"2022).":[97],"Following":[98],"screening,":[99],"completed":[101],"an":[102,233,313,326,347,362,387],"online":[103],"concept":[104],"elicitation":[105],"cognitive":[107],"interview.":[109],"A":[110],"qualitative":[111],"analysis":[112,286],"plan":[113],"was":[114,219],"developed":[115],"aid":[117],"interview":[118],"analysis.":[119],"Results:":[120],"Overall,":[121],"21":[122],"debriefed":[124],"(DS,":[127],"n=10;":[128],"LGS,":[129],"n=11;":[130],"100%":[131],"female;":[132],"mean":[133,144,148,152],"age":[134,145,149,153],"41":[135],"years);":[136],"all":[137],"parents":[139],"(61.9%":[142],"male;":[143],"10.1;":[146],"7.3;":[150],"12.7).":[154],"able":[157],"describe":[159,176],"their":[160,181,250],"child\u2019s":[161],"status":[162],"easily":[163],"using":[164],"baseline":[166],"item":[167,188,202,209,229],"descriptions":[168],"use":[171],"response":[173],"scale":[174,235],"levels":[177],"child.":[182,251],"All":[183,196,204],"understood":[185,197,205],"communication":[187],"(n=21)":[189],"most":[191,212],"found":[192,199,213],"it":[193,214],"relevant":[194,215,262],"(n=20).":[195],"relevant.":[203],"behavior":[208],"(n=20)":[210],"(n=19)":[216],"(one":[217],"not":[220],"debriefed).":[221],"Most":[222],"that":[224,240,256],"asked":[226],"ranked":[227],"each":[228,244,275],"as":[230,312,325,346,361,386],"\u22657":[231],"importance":[234],"0\u201310,":[237],"reported":[239],"minimal":[241,272],"improvement":[242,273],"in":[243,274,281,335],"domain":[245,276],"would":[246,277],"be":[247],"meaningful":[248,279],"Conclusions:":[252],"Caregiver":[253],"indicated":[255],"items":[259],"represented":[260],"highly":[261],"nonseizure":[263],"outcomes":[264,280],"easy":[267],"understand":[269],"use;":[271],"represent":[278],"these":[282],"core":[283],"areas.":[284],"Further":[285],"planned":[288],"following":[289],"completion":[290],"ongoing":[292],"phase":[293],"3":[294],"studies.":[295],"Study":[296],"funded":[297],"Takeda":[299,329,336,390],"Pharmaceutical":[300],"Company":[301],"Limited.":[302],"Disclosure:":[303],"Dr.":[304,317,331,366,378],"Shah":[305],"has":[306,319,333,340,355,368,374,380,394],"received":[307,320,341,356,381],"personal":[308,321,342,357,382],"compensation":[309,322,343,358,383],"serving":[311,324,345,360,385],"employee":[314,327,348,363,388],"Takeda.":[316],"Andrews":[318,332],"Pharmaceuticals.":[330,337],"stock":[334],"Ms.":[338,353],"Nacson":[339,354],"Outcomes":[351],"Solutions.":[352],"IQVIA.":[365],"Symonds":[367],"nothing":[369,375,395],"disclose.":[371,377,397],"Miss":[372,392],"Hughes":[373],"Benitez":[379],".":[391],"Sams":[393]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-29T00:00:00"}